Cytokinetics Stock Price Patterns
| CYTK Stock | USD 66.26 1.22 1.88% |
Momentum 53
Impartial
Oversold | Overbought |
Using Cytokinetics hype-based prediction, you can estimate the value of Cytokinetics from the perspective of Cytokinetics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cytokinetics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cytokinetics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cytokinetics after-hype prediction price | USD 66.25 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cytokinetics | Build AI portfolio with Cytokinetics Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cytokinetics After-Hype Price Density Analysis
As far as predicting the price of Cytokinetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytokinetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cytokinetics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cytokinetics Estimiated After-Hype Price Volatility
In the context of predicting Cytokinetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytokinetics' historical news coverage. Cytokinetics' after-hype downside and upside margins for the prediction period are 63.71 and 68.79, respectively. We have considered Cytokinetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cytokinetics is very steady at this time. Analysis and calculation of next after-hype price of Cytokinetics is based on 3 months time horizon.
Cytokinetics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cytokinetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytokinetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytokinetics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 2.54 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
66.26 | 66.25 | 0.02 |
|
Cytokinetics Hype Timeline
Cytokinetics is currently traded for 66.26. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cytokinetics is anticipated to decline in value after the next headline, with the price expected to drop to 66.25. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -0.02%, whereas the daily expected return is currently at 0.01%. The volatility of related hype on Cytokinetics is about 4156.36%, with the expected price after the next announcement by competition of 66.26. About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 6.3. Cytokinetics had not issued any dividends in recent years. The entity had 1:6 split on the 25th of June 2013. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Cytokinetics Basic Forecasting Models to cross-verify your projections.Cytokinetics Related Hype Analysis
Having access to credible news sources related to Cytokinetics' direct competition is more important than ever and may enhance your ability to predict Cytokinetics' future price movements. Getting to know how Cytokinetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytokinetics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NUVL | Nuvalent | 0.00 | 0 per month | 0.00 | (0.06) | 2.94 | (3.90) | 15.70 | |
| ABVX | Abivax SA American | 0.00 | 0 per month | 3.41 | 0.04 | 6.29 | (6.09) | 29.38 | |
| AXSM | Axsome Therapeutics | 0.00 | 0 per month | 1.38 | 0.1 | 4.08 | (2.36) | 26.78 | |
| RYTM | Rhythm Pharmaceuticals | 0.00 | 0 per month | 2.83 | (0.02) | 4.76 | (4.28) | 18.69 | |
| HALO | Halozyme Therapeutics | 0.00 | 0 per month | 1.80 | 0.07 | 3.72 | (2.90) | 9.83 | |
| MTSR | Metsera Common Stock | (0.13) | 8 per month | 2.40 | 0.17 | 14.25 | (4.09) | 75.60 | |
| JAZZ | Jazz Pharmaceuticals PLC | 0.00 | 0 per month | 0.00 | (0.05) | 1.85 | (3.14) | 11.52 | |
| CORT | Corcept Therapeutics Incorporated | 0.00 | 0 per month | 0.00 | (0.09) | 6.44 | (8.51) | 54.02 | |
| CRSP | Crispr Therapeutics AG | (0.42) | 19 per month | 0.00 | (0.02) | 6.23 | (5.12) | 19.81 |
Cytokinetics Additional Predictive Modules
Most predictive techniques to examine Cytokinetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytokinetics using various technical indicators. When you analyze Cytokinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cytokinetics Predictive Indicators
The successful prediction of Cytokinetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cytokinetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cytokinetics based on analysis of Cytokinetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cytokinetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytokinetics's related companies.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Cytokinetics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. Projected growth potential of Cytokinetics fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytokinetics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cytokinetics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytokinetics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cytokinetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.